PARTNER randomised, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum based neoadjuvant chemotherapy in triple negative and/or germline BRCA mutated breast cancer patients.
Abraham, J Vallier, A Qian, W Grybowicz, L Thomas, S Machin, A Harvey, C Chiu, E McAdam, K Hughes-Davies, L
Abraham, J
Vallier, A
Qian, W
Grybowicz, L
Thomas, S
Machin, A
Harvey, C
Chiu, E
McAdam, K
Hughes-Davies, L
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018-02-14
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
PARTNER randomised, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum based neoadjuvant chemotherapy in triple negative and/or germline BRCA mutated breast cancer patients 2018, 78(4 Suppl): OT3-04-03 Cancer Res